Cytomegalovirus Antibody |
GWB-63640D |
GenWay Biotech |
0.1 mg |
Ask for price |
Cytomegalovirus Antibody Laboratories manufactures the antibody cytomegalovirus reagents distributed by Genprice. The Antibody Cytomegalovirus reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other Antibody products are available in stock. Specificity: Antibody Category: Cytomegalovirus
JBS True Blue |
MiTeGen |
300 µl |
EUR 16 |
Description: JBS True Blue |
Test Assays information
Cytomegalovirus (CMV) Antibody; gB |
MBS568163-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2855 |
Cytomegalovirus (CMV) Antibody; gB |
MBS568198-05mg |
MyBiosource |
0.5mg |
EUR 680 |
Cytomegalovirus (CMV) Antibody; gB |
MBS568198-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2855 |
Cytomegalovirus (CMV) Antibody; gB |
MBS568216-01mg |
MyBiosource |
0.1mg |
EUR 455 |
Cytomegalovirus (CMV) Antibody; gB |
MBS568216-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1840 |
Cytomegalovirus (CMV) Antibody; gB |
MBS568224-05mg |
MyBiosource |
0.5mg |
EUR 680 |
Cytomegalovirus (CMV) Antibody; gB |
MBS568224-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2855 |
Cytomegalovirus (CMV) Antibody; gB |
MBS568294-05mg |
MyBiosource |
0.5mg |
EUR 680 |
Cytomegalovirus (CMV) Antibody; gB |
MBS568294-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2855 |
Cytomegalovirus (CMV) Antibody; gB |
MBS568380-05mg |
MyBiosource |
0.5mg |
EUR 680 |
Cytomegalovirus (CMV) Antibody; gB |
MBS568380-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2855 |
Cytomegalovirus (CMV) Antibody; IE1 |
MBS568208-05mg |
MyBiosource |
0.5mg |
EUR 680 |
Cytomegalovirus (CMV) Antibody; IE1 |
MBS568208-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2855 |
Cytomegalovirus Antibody / CMV / PP65 |
V2332-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2332-20UG |
NSJ Bioreagents |
20 ug |
EUR 186.15 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2332SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2333-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |